会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Esters and amides containing the
1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetyl moiety
    • 含有1-(4-氯苯甲酰基)-5-甲氧基-2-甲基-1H-吲哚-3-乙酰基部分的酯和酰胺
    • US4362738A
    • 1982-12-07
    • US158587
    • 1980-06-11
    • Johannes KeckGerd KrugerHelmut PieperKlaus NollGunther EngelhardtNorbert PrombergerRainer Zimmermann
    • Johannes KeckGerd KrugerHelmut PieperKlaus NollGunther EngelhardtNorbert PrombergerRainer Zimmermann
    • C07D209/08A61K31/495A61P29/00C07C67/00C07C227/00C07C227/16C07C227/18C07C229/54C07C237/32C07C237/38C07C313/00C07C323/12C07C323/65C07D209/28C07D213/74C07D295/088C07D295/155C07D401/12C07H13/08C07D279/18A61K27/00
    • C07D213/74C07D209/28C07D295/088C07D295/155
    • Compounds of the formula ##STR1## wherein each X, which may be identical or different from the other X, is oxygen or imino;R.sub.1 is hydrogen, fluorine, chlorine or bromine;R.sub.2 and R.sub.3, which may be identical or different from each other, are each hydrogen; unsubstituted or mono-substituted alkyl of 1 to 6 carbon atoms, where the substituent is phenyl or dialkylamino with 1 to 3 carbon atoms in each alkyl moiety; pyridyl; or cycloalkyl of 5 to 7 carbon atoms;R.sub.2 and R.sub.3, together with each other and the nitrogen atoms to which they are attached, are pyrrolidino, piperidino, hexamethyleneimino, morpholino, N-aryl-piperazino or N-(alkyl of 1 to 3 carbon atoms)-piperazino;A is cycloalkylene of 5 to 7 carbon atoms; unsubstituted or substituted alkylene of 2 to 10 carbon atoms, where the substituents are one to two alkyls of 1 to 3 carbon atoms each, one to two carbalkoxys of 2 to 4 carbon atoms each, one to two phenyls, one to four hydroxyls, one halomethyl, one hydroxymethyl, one alkanoyloxy of 1 to 18 carbon atoms, one alkanoyloxymethyl of 1 to 18 carbon atoms in the alkanoyl moiety or one ##STR2## where R.sub.1, R.sub.2 and R.sub.3 have the meanings previously defined; or alkylene of 2 to 10 carbon atoms interrupted by oxygen, sulfur, sulfoxide, sulfonyl, phenyl, cyclohexyl, pyridyl, piperazino or unsubstituted or substituted imino, where the substituent on the imino group is alkyl of 1 to 6 carbon atoms, phenyl or phenylalkyl of 1 to 3 carbon atoms in the alkyl moiety;B is the acyl residue of an antiphlogistic carboxylic acid;and their non-toxic, pharmacologically acceptable acid addition salts. The compounds as well as their salts are useful as anti-inflammatories.
    • 其中每个X可以相同或不同于另一个X的式“IMAGE”的化合物是氧或亚氨基; R1是氢,氟,氯或溴; R2和R3可以相同或不同,分别为氢; 未取代或单取代的1至6个碳原子的烷基,其中取代基为苯基或每个烷基部分具有1至3个碳原子的二烷基氨基; 吡啶基 或5至7个碳原子的环烷基; 吡咯烷基,哌啶子基,六亚甲基亚氨基,吗啉代,N-芳基 - 哌嗪子基或N-(1至3个碳原子的烷基) - 哌嗪基; R 2和R 3彼此连接并连接的氮原子。 A是5至7个碳原子的亚环烷基; 2至10个碳原子的未取代或取代的亚烷基,其中取代基为1至2个碳原子数为1至2个的烷基,每个为2至4个碳原子的1至2个碳烷氧基,1至2个苯基,1至4个羟基,1至2个 卤代甲基,一个羟甲基,一个1至18个碳原子的烷酰氧基,一个在烷酰基部分中具有1至18个碳原子的烷酰氧基甲基或一个,其中R1,R2和R3具有以前定义的含义; 或由氧,硫,亚砜,磺酰基,苯基,环己基,吡啶基,哌嗪子基或未取代或取代的亚氨基所取代的2至10个碳原子的亚烷基,其中亚氨基上的取代基是1至6个碳原子的烷基,苯基或苯基烷基 在烷基部分中具有1至3个碳原子; B是消炎性羧酸的酰基残基; 及其无毒,药理学上可接受的酸加成盐。 化合物及其盐可用作抗炎剂。
    • 7. 发明授权
    • Substituted bis-(4-aminophenyl)-sulfones
    • 取代的双 - (4-氨基苯基) - 砜
    • US4829058A
    • 1989-05-09
    • US62291
    • 1987-06-15
    • Joachim K. SeydelHelmut PieperGerd KrugerKlaus NollJohannes KeckUwe Lechner
    • Joachim K. SeydelHelmut PieperGerd KrugerKlaus NollJohannes KeckUwe Lechner
    • C12N9/99A61K31/135A61K31/165A61K31/24A61K31/275A61K31/505A61P31/04A61P33/00A61P43/00C07C67/00C07C205/26C07C205/34C07C313/00C07C315/04C07C317/36C07C317/48
    • C07C205/34C07C205/26C07C317/00C07C323/00
    • Disclosed are substituted bis(4-aminophenyl)-sulfones of general formula ##STR1## wherein R.sub.1 is hydrogen, alkyl or cycloalkyl; group,R.sub.2 is hydrogen or C.sub.1 -C.sub.3 alkyl,R.sub.3 is nitrile, C.sub.1 -C.sub.3 alkylaminocarbonyl, di C.sub.1 -C.sub.3 alkylaminocarbonyl, C.sub.3 -C.sub.7 N-cycloalkyl-C.sub.1 -C.sub.3 alkylaminocarbonyl C.sub.1 -C.sub.3 alkylamino, C.sub.1 -C.sub.3, di alkylaminocarbonyl alkoxy, alkylaminosulfonyl, di C.sub.1 -C.sub.3 alkylaminono, diC.sub.1 -C.sub.3 alkylaminosulfonyl, hydroxy C.sub.1 -C.sub.3 alkyl, C.sub.1 -C.sub.3 alkylcarbonyl, amino C.sub.1 -C.sub.3 alkyl or C.sub.1 -C.sub.3 alkoxy C.sub.1 -C.sub.3 alkyl groupor, when R.sub.1 and R.sub.2 are each hydrogen, R.sub.3 can be hydroxy, hydroxycarbonyl C.sub.1 -C.sub.3 alkoxy or di C.sub.1 -C.sub.3 aminocarbonylalkoxy;or, when R.sub.1 is C.sub.1 -C.sub.3 alkyl or C.sub.1 -C.sub.3 cycloalkyl and R.sub.2 is hydrogen or C.sub.1 -C.sub.3 alkyl, R.sub.3 can also be halogen, trifluoromethyl, nitro, amino, aminosulfonyl, aminocarbonyl, C.sub.1 -C.sub.3 alkyl, carboxy or C.sub.1 -C.sub.3 alkoxycarbonyl; andR.sub.4 is hydrogen or, when R.sub.1 and R.sub.2 are each hydrogen and R.sub.3 is halogen or hydroxy, R.sub.4 can also be halogen, hydroxy or C.sub.1 -C.sub.3 alkoxy; or a nontoxic, pharmaceutically acceptable salt thereof. Also disclosed are pharmaceutical compositions comprising such compounds alone and in combination with dihydrofolic acid-reductase inhibitors. The compounds and compositions are useful for their inhibiting effect on bacteria, mycobacteria and plasmodia.
    • 公开了通式为(I)的取代的双(4-氨基苯基) - 砜,其中R 1是氢,烷基或环烷基; 基团,R 2是氢或C 1 -C 3烷基,R 3是腈,C 1 -C 3烷基氨基羰基,C 2 -C 3烷基氨基羰基,C 3 -C 7 N-环烷基-C 1 -C 3烷基氨基羰基C 1 -C 3烷基氨基,C 1 -C 3,二烷基氨基羰基烷氧基, 烷基氨基磺酰基,二C1-C3烷基氨基亚氨基,二C1-C3烷基氨基磺酰基,羟基C1-C3烷基,C1-C3烷基羰基,氨基C1-C3烷基或C1-C3烷氧基C1-C3烷基,或当R1和R2各自为氢时,R3 可以是羟基,羟基羰基C1-C3烷氧基或二C1-C3氨基羰基烷氧基; 或者当R1是C1-C3烷基或C1-C3环烷基,R2是氢或C1-C3烷基时,R3也可以是卤素,三氟甲基,硝基,氨基,氨基磺酰基,氨基羰基,C1-C3烷基,羧基或C1-C3 烷氧基羰基 并且R 4是氢,或者当R 1和R 2各自为氢且R 3为卤素或羟基时,R 4也可以是卤素,羟基或C 1 -C 3烷氧基; 或其无毒的药学上可接受的盐。 还公开了单独包含这些化合物并与二氢叶酸还原酶抑制剂组合的药物组合物。 化合物和组合物可用于其对细菌,分枝杆菌和疟原虫的抑制作用。